- Home
- SAIH vs IPA Comparison
SAIH vs IPA Comparison
Compare SAIH & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAIH
- IPA
- Stock Information
- Founded
- SAIH 2019
- IPA 1983
- Country
- SAIH Singapore
- IPA Canada
- Employees
- SAIH N/A
- IPA N/A
- Industry
- SAIH
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- SAIH
- IPA Health Care
- Exchange
- SAIH NYSE
- IPA Nasdaq
- Market Cap
- SAIH 17.1M
- IPA 15.3M
- IPO Year
- SAIH N/A
- IPA 2017
- Fundamental
- Price
- SAIH $0.70
- IPA $0.53
- Analyst Decision
- SAIH
- IPA Strong Buy
- Analyst Count
- SAIH 0
- IPA 2
- Target Price
- SAIH N/A
- IPA $5.00
- AVG Volume (30 Days)
- SAIH 89.5K
- IPA 422.7K
- Earning Date
- SAIH 11-13-2024
- IPA 03-13-2025
- Dividend Yield
- SAIH N/A
- IPA N/A
- EPS Growth
- SAIH N/A
- IPA N/A
- EPS
- SAIH N/A
- IPA N/A
- Revenue
- SAIH $6,954,000.00
- IPA $17,272,336.00
- Revenue This Year
- SAIH N/A
- IPA $1.88
- Revenue Next Year
- SAIH N/A
- IPA $9.90
- P/E Ratio
- SAIH N/A
- IPA N/A
- Revenue Growth
- SAIH N/A
- IPA 6.36
- 52 Week Low
- SAIH $0.54
- IPA $0.33
- 52 Week High
- SAIH $1.80
- IPA $2.60
- Technical
- Relative Strength Index (RSI)
- SAIH N/A
- IPA 58.77
- Support Level
- SAIH N/A
- IPA $0.43
- Resistance Level
- SAIH N/A
- IPA $0.59
- Average True Range (ATR)
- SAIH 0.00
- IPA 0.07
- MACD
- SAIH 0.00
- IPA 0.01
- Stochastic Oscillator
- SAIH 0.00
- IPA 71.48
About SAIH SAIHEAT LIMITED
Saiheat Ltd develops technologies for the advanced Computing Center Ecosystem (ACCE), a next-gen computing center featuring high-performance servers, advanced liquid cooling, and systems for capturing and recycling computing heat. It aims to reduce the carbon footprint of Bitcoin mining and AI operations.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges.